Location: New York, NY
CIK: 0001746382 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $363M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ESPR | ESPERION THERAPEUTICS INC NE | 2,515,785 | $12.58M | 3.5% | $8.01 | 0.0% | COM | 29664W105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 346,000 | $11.83M | 3.3% | $27.44 | +15.2% | COM | 74366E102 |
| — | BELLUS HEALTH INC NEW | 1,450,006 | $11.67M | 3.2% | $3.07 | — | COM NEW | 07987C204 |
| BCYC | BICYCLE THERAPEUTICS PLC | 172,000 | $10.47M | 2.9% | $50.56 | — | SPONSORED ADS | 088786108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 331,000 | $9.404M | 2.6% | $19.08 | +29.2% | COM | 22663K107 |
| — | CHINOOK THERAPEUTICS INC | 545,000 | $8.889M | 2.5% | $14.98 | — | COM | 16961L106 |
| LNTH | LANTHEUS HLDGS INC | 272,000 | $7.858M | 2.2% | $15.53 | +71.3% | COM | 516544103 |
| POLWQ | 1847 GOEDEKER INC | 6,103,824 | $7.386M | 2.0% | $2.14 | — | *W EXP 99/99/999 | 28252C117 |
| — | PEPPERLIME HEALTH ACQUSTN CO | 735,000 | $7.203M | 2.0% | $9.80 | — | CLASS A ORD SHS | G70021103 |
| KROS | KEROS THERAPEUTICS INC | 116,000 | $6.787M | 1.9% | $35.59 | +40.1% | COM | 492327101 |
| ILMN | ILLUMINA INC | 17,500 | $6.658M | 1.8% | $360.66 | +5.1% | COM | 452327109 |
| IMTX | IMMATICS N.V | 469,980 | $6.317M | 1.7% | $11.15 | +12.0% | SHS | N44445109 |
| — | NANOSTRING TECHNOLOGIES INC | 146,500 | $6.187M | 1.7% | $42.23 | — | COM | 63009R109 |
| — | CYMABAY THERAPEUTICS INC | 1,750,000 | $5.915M | 1.6% | $3.38 | — | COM | 23257D103 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 300,000 | $5.727M | 1.6% | — | — | Call | 462260100 |
| INSM | INSMED INC | 203,354 | $5.539M | 1.5% | $33.39 | -14.4% | COM PAR $.01 | 457669307 |
| — | IVERIC BIO INC | 329,101 | $5.503M | 1.5% | $6.91 | — | COM | 46583P102 |
| — | CTI BIOPHARMA CORP | 2,185,000 | $5.419M | 1.5% | $2.62 | — | COM | 12648L601 |
| RNAM | AVIDITY BIOSCIENCES INC | 225,000 | $5.348M | 1.5% | $23.98 | -0.4% | COM | 05370A108 |
| INSP | INSPIRE MED SYS INC | 23,000 | $5.291M | 1.5% | $200.46 | +21.8% | COM | 457730109 |
| MYGN | MYRIAD GENETICS INC | 190,000 | $5.244M | 1.4% | $18.31 | +58.2% | COM | 62855J104 |
| — | QIAGEN NV | 93,000 | $5.169M | 1.4% | $55.58 | — | SHS NEW | N72482123 |
| — | NOCTURNE ACQUISITION CORP | 500,000 | $5M | 1.4% | $9.86 | — | ORDINARY SHARES | G6580S114 |
| — | QUIDEL CORP | 37,000 | $4.995M | 1.4% | $135.00 | — | COM | 74838J101 |
| — | ESSA PHARMA INC | 345,000 | $4.899M | 1.4% | $14.20 | — | COM NEW | 29668H708 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 126,000 | $4.869M | 1.3% | $34.82 | +25.1% | COM NEW | 15117B202 |
| OCUL | OCULAR THERAPEUTIX INC | 695,000 | $4.844M | 1.3% | $11.99 | -35.2% | COM | 67576A100 |
| ADMA | ADMA BIOLOGICS INC | 3,300,000 | $4.653M | 1.3% | $1.31 | 0.0% | COM | 000899104 |
| RLMD | RELMADA THERAPEUTICS INC | 206,000 | $4.641M | 1.3% | $22.24 | 0.0% | COM | 75955J402 |
| — | VERASTEM INC | 2,253,000 | $4.619M | 1.3% | $2.36 | — | COM | 92337C104 |
| — | ADICET BIO INC | 263,000 | $4.6M | 1.3% | $15.10 | — | COM | 007002108 |
| TVTX | TRAVERE THERAPEUTICS INC | 141,000 | $4.377M | 1.2% | $26.07 | +8.0% | COM | 89422G107 |
| — | KALEYRA INC | 433,892 | $4.356M | 1.2% | $12.24 | — | COM | 483379103 |
| GMED | GLOBUS MED INC | 59,000 | $4.26M | 1.2% | $66.42 | +9.3% | CL A | 379577208 |
| — | CURIS INC | 829,000 | $3.946M | 1.1% | $8.18 | — | COM NEW | 231269200 |
| — | EUCRATES BIOMEDICAL ACQU COR | 400,000 | $3.904M | 1.1% | $9.85 | — | SHS | G3141W106 |
| — | SYROS PHARMACEUTICALS INC | 1,160,000 | $3.782M | 1.0% | $5.50 | — | COM | 87184Q107 |
| GKOS | GLAUKOS CORP | 81,000 | $3.6M | 1.0% | $46.16 | 0.0% | COM | 377322102 |
| — | AVADEL PHARMACEUTICALS PLC | 440,589 | $3.56M | 1.0% | $6.68 | — | SPONSORED ADR | 05337M104 |
| XTNT | XTANT MED HLDGS INC | 6,246,291 | $3.498M | 1.0% | $1.78 | -47.0% | COM NEW | 98420P308 |
| EXAS | EXACT SCIENCES CORP | 44,000 | $3.425M | 0.9% | $88.25 | 0.0% | COM | 30063P105 |
| — | NEVRO CORP | 42,000 | $3.405M | 0.9% | $128.57 | — | COM | 64157F103 |
| PROF | PROFOUND MED CORP | 300,000 | $3.369M | 0.9% | $19.27 | -35.2% | COM NEW | 74319B502 |
| — | PARDES BIOSCIENCES INC | 200,000 | $3.274M | 0.9% | $16.37 | — | COM | 69945Q105 |
| NTRA | NATERA INC | 35,000 | $3.269M | 0.9% | $105.62 | -1.7% | COM | 632307104 |
| — | SIENTRA INC | 866,000 | $3.178M | 0.9% | $3.67 | — | COM | 82621J105 |
| CERS | CERUS CORP | 465,000 | $3.167M | 0.9% | $5.85 | +15.0% | COM | 157085101 |
| IMUX | IMMUNIC INC | 317,000 | $3.034M | 0.8% | $9.01 | 0.0% | COM | 4525EP101 |
| — | RENOVACOR INC | 388,845 | $2.994M | 0.8% | $9.05 | — | COM | 75989E106 |
| KRMD | REPRO MED SYS INC | 995,500 | $2.987M | 0.8% | $3.75 | -18.2% | COM | 759910102 |
| INFU | INFUSYSTEM HLDGS INC | 175,000 | $2.98M | 0.8% | $15.87 | 0.0% | COM | 45685K102 |
| ATEC | ALPHATEC HLDGS INC | 255,000 | $2.915M | 0.8% | $11.81 | 0.0% | COM NEW | 02081G201 |
| — | HARBOR CUSTOM DEVELOPMENT IN | 185,000 | $2.901M | 0.8% | $15.68 | — | 8% CONV PFD SR A | 41150T207 |
| CTMX | CYTOMX THERAPEUTICS INC | 663,800 | $2.874M | 0.8% | $6.93 | -15.5% | COM | 23284F105 |
| — | MORPHIC HLDG INC | 60,000 | $2.843M | 0.8% | $61.12 | — | COM | 61775R105 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 225,000 | $2.754M | 0.8% | $10.89 | +23.6% | COM NEW | 30233G209 |
| — | TURMERIC ACQUISITION CORP | 254,000 | $2.494M | 0.7% | $9.89 | — | CL A | G9127T108 |
| MLTX | HELIX ACQUISITION CORP | 250,000 | $2.473M | 0.7% | $11.37 | — | COM CL A | G4444C102 |
| STAA | STAAR SURGICAL CO | 26,000 | $2.374M | 0.7% | $107.29 | 0.0% | COM PAR $0.01 | 852312305 |
| LEGN | LEGEND BIOTECH CORP | 50,000 | $2.331M | 0.6% | $46.62 | — | SPONSORED ADS | 52490G102 |
| — | SARISSA CAPITAL ACQUISITN CO | 225,000 | $2.203M | 0.6% | $9.86 | — | CL A | G7823W102 |
| — | TG VENTURE ACQUISITION CORP | 200,000 | $2.05M | 0.6% | $10.25 | — | UNIT 08/15/2028 | 87251T208 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 24,000 | $2.034M | 0.6% | $82.16 | 0.0% | COM | 558868105 |
| CRDF | CARDIFF ONCOLOGY INC | 337,000 | $2.025M | 0.6% | $8.48 | -29.7% | COM | 14147L108 |
| — | GIGINTERNATIONAL1 INC | 200,000 | $1.986M | 0.5% | $9.87 | — | COM | 37518W106 |
| DYN | DYNE THERAPEUTICS INC | 166,636 | $1.981M | 0.5% | $19.35 | -27.4% | COM | 26818M108 |
| — | LAKESHORE ACQUISITION I CORP | 200,000 | $1.972M | 0.5% | $9.83 | — | ORDINARY SHARES | G53521103 |
| — | CHAVANT CAPITAL ACQUISITN CO | 200,000 | $1.968M | 0.5% | $9.85 | — | ORDINARY SHARES | G2058L103 |
| — | JIYA ACQUISITION CORP | 200,000 | $1.954M | 0.5% | $10.30 | — | COM CL A | 47760M102 |
| — | 89BIO INC | 148,000 | $1.934M | 0.5% | $13.07 | — | COM | 282559103 |
| CELC | CELCUITY INC | 145,000 | $1.913M | 0.5% | $25.73 | -37.8% | COM | 15102K100 |
| VQSSF | VIQ SOLUTIONS INC | 704,687 | $1.642M | 0.5% | $5.22 | -53.0% | COM NEW | 91825V400 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 54,000 | $1.581M | 0.4% | $29.28 | — | COM | 37890U108 |
| — | DIGITAL HEALTH ACQUISITION C | 150,000 | $1.536M | 0.4% | $10.24 | — | UNIT 11/02/2026 | 253893200 |
| — | FAT BRANDS INC | 227,000 | $1.533M | 0.4% | $2.70 | — | *W EXP 07/16/202 | 30258N121 |
| HLMN | HILLMAN SOLUTIONS CORP | 142,000 | $1.527M | 0.4% | $12.24 | -12.1% | COM | 431636109 |
| — | AULT DISRUPTIVE TECHS CORP | 150,000 | $1.52M | 0.4% | $10.13 | — | UNIT 99/99/9999 | 05150A203 |
| FLUX | FLUX PWR HLDGS INC | 346,268 | $1.485M | 0.4% | $8.45 | -37.1% | COM NEW | 344057302 |
| KALV | KALVISTA PHARMACEUTICALS INC | 111,834 | $1.48M | 0.4% | $26.28 | -39.4% | COM | 483497103 |
| — | MUSCLE MAKER INC | 1,995,882 | $1.437M | 0.4% | $0.72 | — | COM | 627333107 |
| — | AEGLEA BIOTHERAPEUTICS INC | 293,764 | $1.395M | 0.4% | $7.36 | — | COM | 00773J103 |
| — | EIGER BIOPHARMACEUTICALS INC | 261,000 | $1.355M | 0.4% | $10.56 | — | COM | 28249U105 |
| CNTX | CONTEXT THERAPEUTICS INC | 493,531 | $1.313M | 0.4% | $4.98 | 0.0% | COM | 21077P108 |
| — | TAILWIND ACQUISITION CORP | 128,414 | $1.264M | 0.3% | $9.92 | — | COM CL A | 87403Q102 |
| — | CITIC CAPITAL ACQUISITION CO | 111,200 | $1.113M | 0.3% | $9.99 | — | COM CL A | G21513109 |
| RZLT | REZOLUTE INC | 230,000 | $1.099M | 0.3% | $5.84 | 0.0% | COM NEW | 76200L309 |
| — | MOTIVE CAPITAL CORP | 102,099 | $1.005M | 0.3% | $9.80 | — | SHS CL A | G6293A103 |
| — | OPY ACQUISITION CORP I | 100,000 | $1M | 0.3% | $10.00 | — | UNIT 09/22/2026 | 671005205 |
| — | INDUSTRIAL HUMAN CAPITAL INC | 100,000 | $992K | 0.3% | $9.92 | — | COM | 45617P104 |
| — | ARYA SCIENCES ACQU CORP IV | 100,000 | $992K | 0.3% | $9.92 | — | CL A | G31659108 |
| — | FIRSTMARK HORIZON ACQUISITIO | 100,000 | $989K | 0.3% | $10.00 | — | CL A COM | 33765Y101 |
| — | BCLS ACQUISITION CORP | 100,000 | $980K | 0.3% | $11.14 | — | COM CL A | G0904B105 |
| — | OMEGA ALPHA SPAC | 100,000 | $977K | 0.3% | $9.90 | — | CL A | G6749V107 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 122,000 | $949K | 0.3% | $9.52 | -17.5% | COM | 004468500 |
| DDI | DOUBLEDOWN INTERACTIVE CO LT | 60,876 | $944K | 0.3% | $17.61 | — | ADS | 25862B109 |
| BBIO | BRIDGEBIO PHARMA INC | 54,300 | $906K | 0.2% | $53.60 | -21.1% | Call | 10806X102 |
| — | CONNECT BIOPHARMA HLDGS LTD | 175,000 | $901K | 0.2% | $5.15 | — | ADS | 207523101 |
| — | VERRICA PHARMACEUTICALS INC | 97,887 | $897K | 0.2% | $14.45 | — | COM | 92511W108 |
| — | COLISEUM ACQUISITION CORP | 85,000 | $826K | 0.2% | $9.95 | — | CLASS A ORD SHS | G2263T123 |
| — | STRYVE FOODS INC | 162,121 | $640K | 0.2% | $5.35 | — | CLASS A COM | 863685103 |
| — | HARBOR CUSTOM DEVELOPMENT IN | 650,000 | $501K | 0.1% | $0.77 | — | *W EXP 10/04/202 | 41150T124 |
| — | COLOMBIER ACQUISITION CORP | 50,000 | $482K | 0.1% | $9.68 | — | CL A | 19533H108 |
| — | ICAD INC | 63,929 | $460K | 0.1% | $10.75 | — | COM NEW | 44934S206 |
| IMMX | IMMIX BIOPHARMA INC | 122,388 | $436K | 0.1% | $3.42 | 0.0% | COM | 45258H106 |
| — | PALISADE BIO INC | 333,954 | $434K | 0.1% | $1.30 | — | COM | 696389105 |
| — | IMMATICS N.V | 97,467 | $428K | 0.1% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| — | RENOVACOR INC | 731,561 | $417K | 0.1% | $0.68 | — | *W EXP 99/99/999 | 75989E114 |
| — | MDXHEALTH SA | 36,159 | $344K | 0.1% | $9.51 | — | SPONSORED ADS | 58286E102 |
| — | HELIUS MED TECHNOLOGIES INC | 48,862 | $254K | 0.1% | $5.20 | — | COM CL A NEW | 42328V603 |
| — | HARBOR CUSTOM DEVELOPMENT IN | 600,000 | $234K | 0.1% | $0.63 | — | *W EXP 05/09/202 | 41150T116 |
| — | CINGULATE INC | 83,931 | $232K | 0.1% | $2.76 | — | COMMON STOCK | 17248W105 |
| AGILQ | AGILETHOUGHT INC | 47,670 | $225K | 0.1% | $8.60 | 0.0% | CLASS A COM | 00857F100 |
| — | MY SIZE INC | 416,589 | $210K | 0.1% | $0.50 | — | COM NEW | 62844N208 |
| — | NOCTURNE ACQUISITION CORP | 500,000 | $200K | 0.1% | $0.38 | — | RIGHT 12/26/2025 | G6580S106 |
| CINGW | CINGULATE INC | 270,000 | $192K | 0.1% | $0.71 | — | *W EXP 12/03/202 | 17248W113 |
| NXGLW | NEXGEL INC | 225,000 | $182K | 0.1% | $0.81 | — | *W EXP 12/01/202 | 65344E115 |
| — | PEPPERLIME HEALTH ACQUSTN CO | 367,500 | $165K | 0.0% | $0.45 | — | *W EXP 10/01/202 | G70021111 |
| — | SURGEPAYS INC | 250,000 | $161K | 0.0% | $0.64 | — | *W EXP 10/22/202 | 86882L113 |
| — | NLS PHARMACEUTICS LTD | 200,000 | $146K | 0.0% | $0.73 | — | *W EXP 09/25/202 | H57830111 |
| — | LAKESHORE ACQUISITION I CORP | 150,000 | $116K | 0.0% | $0.53 | — | *W EXP 07/15/202 | G53521111 |
| — | HEALTH SCIENCES ACQ CORP 2 | 10,000 | $101K | 0.0% | $12.80 | — | ORD SHS | G4411D109 |
| SRZNW | SURROZEN INC | 82,233 | $95,000 | 0.0% | $1.14 | — | *W EXP 08/01/203 | 86889P117 |
| — | EUCRATES BIOMEDICAL ACQU COR | 133,333 | $77,000 | 0.0% | $1.04 | — | *W EXP 10/23/202 | G3141W122 |
| NXGL | NEXGEL INC | 28,570 | $75,000 | 0.0% | $2.95 | 0.0% | COM | 65344E107 |
| — | CHAVANT CAPITAL ACQUISITN CO | 150,000 | $74,000 | 0.0% | $0.48 | — | *W EXP 99/99/999 | G2058L111 |
| — | SARISSA CAPITAL ACQUISITN CO | 75,000 | $71,000 | 0.0% | $1.00 | — | *W EXP 10/23/202 | G7823W110 |
| RSVRW | RESERVOIR MEDIA INC | 50,000 | $70,000 | 0.0% | $1.98 | — | *W EXP 08/26/202 | 76119X113 |
| — | TURMERIC ACQUISITION CORP | 84,666 | $51,000 | 0.0% | $0.92 | — | *W EXP 10/08/202 | G9127T124 |
| — | INDUSTRIAL HUMAN CAPITAL INC | 100,000 | $38,000 | 0.0% | $0.38 | — | *W EXP 11/27/202 | 45617P112 |
| — | GIGINTERNATIONAL1 INC | 50,000 | $29,000 | 0.0% | $0.74 | — | *W EXP 04/19/202 | 37518W114 |
| — | COLISEUM ACQUISITION CORP | 28,333 | $23,000 | 0.0% | $0.81 | — | *W EXP 08/22/202 | G2263T107 |
| — | COLOMBIER ACQUISITION CORP | 16,666 | $9,000 | 0.0% | $0.54 | — | *W EXP 99/99/999 | 19533H116 |
| UPHLW | UPHEALTH INC | 10,000 | $3,000 | 0.0% | $0.90 | — | *W EXP 06/08/202 | 91532B119 |